Pulmonary arterial hypertension treatment after diagnosis

Start with the confirmed diagnosis

Pulmonary arterial hypertension, or PAH, is one particular form of pulmonary hypertension. Treatments for PAH differ from those used when high lung pressures come from left-heart disease, chronic lung disease or old blood clots. Bring the right-heart catheterization report and the specialist's diagnostic summary to a treatment review.

This guide focuses on what happens after confirmation. If the diagnosis is still uncertain, begin with our guide to distinguishing PAH from other forms of pulmonary hypertension. Getting that distinction right prevents an appointment from becoming a discussion of medicines intended for a different condition.

Sources and references: [1]

Why the team keeps assessing risk

Risk assessment combines how you feel with measurements of heart function and exercise capacity. Symptoms, functional class, walking tests, blood markers and imaging help the team judge whether the current plan is doing enough. A single pressure reading is only one part of that assessment.

Before the visit, record what has changed: stopping halfway up stairs, needing help with shopping or taking longer to recover after walking. These observations make the results easier to interpret. Ask the clinician to explain your treatment goal and what would trigger an earlier review.

Sources and references: [1] [2]

How medicine combinations are chosen

PAH medicines act on different pathways involved in narrowing of the pulmonary vessels. Endothelin receptor antagonists and phosphodiesterase type 5 inhibitors are among the established drug groups. Specialists may combine treatments from the outset or adjust them as risk and response change.

The prescription also has to fit other illnesses, interactions and the treatment you can sustain at home. Bring generic drug names, doses and reasons for previous changes. A medicine stopped because of a side effect tells a different story from one that was tolerated but did not control the disease.

Sources and references: [1] [3]

Where newer treatment fits

Sotatercept is an activin signaling inhibitor approved in the United States for adults with PAH. It offers another treatment approach, with monitoring of hemoglobin and platelets. Important risks include excessive red-cell levels, low platelets, serious bleeding and severe allergic reactions. Pregnancy and fertility considerations also need discussion.

For a Shanghai consultation, ask whether sotatercept fits your current treatment and risk profile. Before planning the visit, confirm the local prescribing route, required blood tests and how follow-up would continue after returning home.

Sources and references: [4]

Follow-up should answer a practical question

Repeated walking tests, blood tests and heart imaging help determine whether to continue, intensify or change treatment. Oxygen may be prescribed when blood oxygen is low. The review should also address treatment burden, including side effects and the work of arranging repeat prescriptions.

Keep the actual reports, with dates and units, rather than a list of results remembered from different visits. Ask who will receive follow-up tests after you return home and who can act on them. A clear handover matters when two clinical teams are involved.

Sources and references: [2] [3]

Activity, pregnancy and travel planning

Activity advice is individualized; supervised rehabilitation can be useful once treatment is optimized and the patient is stable. Discuss exertion limits and oxygen needs before planning flights or travel at altitude. Build rest and assistance into the journey rather than testing your endurance in an airport.

Pregnancy carries substantial risk in PAH and some medicines can harm a fetus. Contact the PAH team promptly if pregnancy is possible or planned. Do not make an abrupt medication change yourself. A joint plan needs to account for both disease control and medication safety.

Sources and references: [1] [2]

Preparing a Shanghai review

Shanghai Pulmonary Hospital, affiliated with Tongji University, is a respiratory specialist resource. For PAH, the relevant enquiry is specifically about a pulmonary vascular team and its ability to review your confirmed diagnosis and treatment history.

EastMedGo can organize the catheterization report, imaging, recent blood results and prescription list for that enquiry. We can help clarify which records need translation and whether a specialist review can address your main question before you arrange travel. Start with the current plan and the change you are hoping to discuss, such as persistent breathlessness or difficulty tolerating a medicine.

Sources and references: [5]

Common questions